We are live on ! Find out more
YCM

Yiheng Capital Management Portfolio holdings

AUM $231M
1-Year Est. Return 29.07%
This Fund
S&P 500
This Quarter Est. Return
-8.02%
1 Year Est. Return
+29.07%
3 Year Est. Return
+63.69%
5 Year Est. Return
+56.64%
10 Year Est. Return
+851.36%
AUM
$2.6B
AUM Growth
+$650M
Cap. Flow
+$1.03B
Cap. Flow %
39.85%
Top 10 Hldgs %
95.29%
Holding
23
New
4
Increased
7
Reduced
5
Closed
–

Top Buys

Rank Stock Value
1
MBLY icon
Mobileye
MBLY
+$11.8M
2
RERE
ATRenew
RERE
+$4.56M
3
RBLX icon
Roblox
RBLX
+$3.67M
4
DNLI icon
Denali Therapeutics
DNLI
+$2.56M
5
ACMR icon
ACM Research
ACMR
+$258K

Top Sells

Rank Stock Value
1
BILI icon
Bilibili
BILI
+$29.8M
2
HTHT icon
Huazhu Hotels Group
HTHT
+$10.8M
3
BEAM icon
Beam Therapeutics
BEAM
+$8.62M
4
AKRO
Akero Therapeutics
AKRO
+$2.81M
5
VRDN icon
Viridian Therapeutics
VRDN
+$2.12M

Sector Composition

Rank Sector Weight
1 Communication Services 4.7%
2 Consumer Discretionary 4.62%
3 Financials 3.03%
4 Healthcare 2.53%
5 Consumer Staples 2.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JD icon
1
CALL
JD.com
JD
$41.5B
$1.33B 51.36%
38,473,800
+19,536,600
+103% +$756M
BILI icon
2
CALL
Bilibili
BILI
$7.81B
$676M 26.02%
37,316,000
+9,576,100
+35% +$200M
ALAB icon
3
PUT
Astera Labs
ALAB
$53.2B
$108M 4.17%
+818,100
New +$76.8M
BILI icon
4
Bilibili
BILI
$7.81B
$88.9M 3.42%
4,908,781
-1,422,493
-22% -$29.8M
NOAH
5
Noah Holdings
NOAH
$612M
$78.7M 3.03%
6,719,722
– –
JD icon
6
JD.com
JD
$41.5B
$52.5M 2.02%
1,513,184
– –
HTHT icon
7
Huazhu Hotels Group
HTHT
$12.8B
$43.2M 1.66%
1,306,395
-297,583
-19% -$10.8M
EDU icon
8
New Oriental
EDU
$7.92B
$33.3M 1.28%
518,314
– –
RBLX icon
9
Roblox
RBLX
$39.5B
$33.2M 1.28%
573,265
+72,882
+15% +$3.67M
SMCI icon
10
PUT
Super Micro Computer
SMCI
$15.7B
$27.4M 1.06%
+900,000
New +$32.7M
TAL icon
11
TAL Education Group
TAL
$5.76B
$21.9M 0.84%
2,187,618
– –
AKRO
12
DELISTED
Akero Therapeutics
AKRO
$18.5M 0.71%
666,145
-92,624
-12% -$2.81M
MBLY icon
13
Mobileye
MBLY
$7.6B
$14.9M 0.58%
+750,000
New +$11.8M
VRDN icon
14
Viridian Therapeutics
VRDN
$2.09B
$14.4M 0.55%
750,261
-97,630
-12% -$2.12M
DNLI icon
15
Denali Therapeutics
DNLI
$3.65B
$14.3M 0.55%
700,098
+100,000
+17% +$2.56M
BEAM icon
16
Beam Therapeutics
BEAM
$2.75B
$10.6M 0.41%
426,102
-337,658
-44% -$8.62M
ACMR icon
17
ACM Research
ACMR
$5.87B
$10.3M 0.4%
680,604
+14,300
+2% +$258K
RERE
18
ATRenew
RERE
$853M
$9.11M 0.35%
3,163,117
+1,639,859
+108% +$4.56M
IVA
19
Inventiva
IVA
$1.06B
$5.66M 0.22%
2,644,926
– –
DBVT
20
DBV Technologies
DBVT
$845M
$2.03M 0.08%
656,309
+25,594
+4% +$87.2K
TOUR
21
Tuniu
TOUR
$56.8M
$321K 0.01%
31,444
– –
GBIO
22
DELISTED
Generation Bio
GBIO
$203K 0.01%
19,153
– –
YSG
23
Yatsen Holding
YSG
$332M
$41.8K ﹤0.01%
+10,508
New +$43.4K

Similar funds

PWA
Prairie Wealth Advisors Omaha, Nebraska $231M AUM 23.67% 1-Year Est. Return
CP
Catalys Pacific Tokyo, Japan $231M AUM 83.19% 1-Year Est. Return
MIM
Meros Investment Management Dallas, Texas $231M AUM 35.94% 1-Year Est. Return
CC
Citrine Capital San Francisco, California $231M AUM 17.28% 1-Year Est. Return
MWM
Massachusetts Wealth Management North Andover, Massachusetts $231M AUM 33.21% 1-Year Est. Return
RF
rebel Financial Groveport, Ohio $231M AUM 12.5% 1-Year Est. Return
CFS
Compass Financial Services West Des Moines, Iowa $231M AUM 11.35% 1-Year Est. Return
ERFOTCOFW
Employees Retirement Fund of the City of Fort Worth Fort Worth, Texas $230M AUM 10.19% 1-Year Est. Return

Yiheng Capital Management's Q4 2024 Portfolio in Review

As of Q4 2024, Yiheng Capital Management held 23 positions worth $2.6B, up 33% from $1.95B the previous quarter. Its ten largest holdings account for 95% of the portfolio.

Yiheng Capital Management deployed $1.03B of net new capital in Q4 2024, opening 4 new positions and adding to 7 existing holdings. Its largest new stake was Mobileye: 750,000 shares worth $14.9M.

By sector, the portfolio is most concentrated in Communication Services at 4.7% of assets, down from 8.7% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Bilibili, an estimated $29.8M trimmed.

  • Yiheng Capital Management's largest Q4 2024 buy was Mobileye: 750,000 shares worth $14.9M.
  • Yiheng Capital Management added most to ATRenew in Q4 2024, an estimated $4.56M increase.
  • Yiheng Capital Management's biggest Q4 2024 reduction was Bilibili, cutting an estimated $29.8M.
  • Yiheng Capital Management's ten largest holdings make up 95% of its $2.6B portfolio in Q4 2024.
  • Yiheng Capital Management opened 4 new positions and closed 0 in Q4 2024.
  • Yiheng Capital Management's portfolio value rose 33% quarter-over-quarter to $2.6B.

Based on Yiheng Capital Management's 13F filing for Q4 2024, filed 11 Feb 2025.